4-46123877-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173536.4(GABRG1):c.37C>A(p.Leu13Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 1,613,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173536.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRG1 | NM_173536.4 | c.37C>A | p.Leu13Ile | missense_variant | 1/9 | ENST00000295452.5 | NP_775807.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRG1 | ENST00000295452.5 | c.37C>A | p.Leu13Ile | missense_variant | 1/9 | 1 | NM_173536.4 | ENSP00000295452 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000359 AC: 90AN: 250390Hom.: 0 AF XY: 0.000266 AC XY: 36AN XY: 135358
GnomAD4 exome AF: 0.000300 AC: 439AN: 1461456Hom.: 0 Cov.: 30 AF XY: 0.000272 AC XY: 198AN XY: 727028
GnomAD4 genome AF: 0.000224 AC: 34AN: 152068Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.37C>A (p.L13I) alteration is located in exon 1 (coding exon 1) of the GABRG1 gene. This alteration results from a C to A substitution at nucleotide position 37, causing the leucine (L) at amino acid position 13 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at